AVAH
Aveanna Healthcare Holdings Inc. Healthcare - Medical Care Facilities Investor Relations →
Aveanna Healthcare Holdings Inc. (AVAH) closed at $6.52 as of 2026-03-20, trading 75.0% above its 200-week moving average of $3.73. The stock is currently moving closer to the line, down from 87.8% last week. With a 14-week RSI of 26, AVAH is in oversold territory.
A big spike in selling this week — 2.2x the usual volume, and the price dropped. Sometimes this kind of heavy selling marks the end of a decline. The idea is that the last reluctant holders have finally sold, leaving fewer sellers left to push the price lower.
Over the past 207 weeks of data, AVAH has crossed below its 200-week moving average 2 times. On average, these episodes lasted 60 weeks. Historically, investors who bought AVAH at the start of these episodes saw an average one-year return of +10.5%.
With a market cap of $1362 million, AVAH is a small-cap stock. The company generates a free cash flow yield of 5.8%, which is healthy. Return on equity stands at 615.7%, indicating strong profitability. The stock trades at 7.0x book value.
Share count has increased 4.6% over three years, indicating dilution.
Over the past 4 years, a hypothetical investment of $100 in AVAH would have grown to $223, compared to $166 for the S&P 500. That represents an annualized return of 22.2% vs 13.6% for the index — confirming AVAH as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: AVAH vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After AVAH Crosses Below the Line?
Across 2 historical episodes, buying AVAH when it crossed below its 200-week moving average produced an average return of -14.0% after 12 months (median +30.0%), compared to +10.5% for the S&P 500 over the same periods. 50% of those episodes were profitable after one year. After 24 months, the average return was -20.0% vs +26.0% for the index.
Each line shows $100 invested at the moment AVAH crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
AVAH has crossed below its 200-week MA 2 times with an average 1-year return of +10.5% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Apr 2022 | Jul 2024 | 120 | 86.7% | -66.7% | +111.0% |
| Mar 2025 | Mar 2025 | 1 | 0.5% | +87.8% | +69.4% |
| Average | 60 | — | +10.5% | — |
Frequently Asked Questions
Is AVAH below its 200-week moving average?
No. Aveanna Healthcare Holdings Inc. (AVAH) is currently 75.0% above its 200-week moving average of $3.73. It would need to fall to $3.73 to cross below the line.
What is AVAH's 200-week moving average price?
Aveanna Healthcare Holdings Inc.'s 200-week moving average is $3.73 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when AVAH drops below its 200-week moving average?
AVAH has crossed below its 200-week moving average 2 times in our data. On average, buying at that moment produced a one-year return of +10.5%. These dips have historically been decent entry points. These episodes lasted 60 weeks on average.
Is AVAH a good value right now?
Here's what our data says about AVAH as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 26 (oversold). Free cash flow yield is 5.8%. Return on equity is 615.7%. Price-to-book is 7.0x. This is not a buy or sell recommendation — always do your own research.
How does AVAH compare to the S&P 500?
Over the past 4 years, $100 invested in AVAH would have grown to $223, compared to $166 for the S&P 500. That's 22.2% annualized vs 13.6% for the index. AVAH has outperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20